Skip to main content

Publications

Click here for NIH author search

Kearns B, McKell A, Steveson I, Worley P, Barton B, Bennett J, Anderson D, Harris J, Christensen J, Barrott JJ. ARID1A and Its Impact Across the Hallmarks of Cancer. Int J Mol Sci. 2025 May 13;26(10):4644.

O’Neal N, Goold E, Zarei Haji Abadi F, Okojie J, Barrott JJ. Papillary Tumor of the Pineal Region Identified by DNA Methylation Leads to Incidental Finding of Germline Mutation PTEN G132D Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Systematic Review. Curr Oncol. 2025 Mar 17;32(3):172.

Fatema K, Wang Y, Pavek A, Larson Z, Nartker C, Plyler S, Jeppsesn A, Mehling B, Jones K, Barrott JJ. piggyBac mutagenesis identifies an interplay between ARID1A deficiency and genomic instability in aggressive osteosarcoma. Cancers (Basel). 2024 Jul 31;16(15):2725.

Okojie J, O’Neal N, Burr M, Worley P, Packer I, Anderson D, Davis J, Kearns B, Fatema K, Booker D, Dixon K, Barrott JJ. DNA quantity and quality comparisons between cryopreserved and FFPE tumors from matched pan-cancer samples. Current Oncology. Curr Oncol. 2024 Apr 28;31(5):2441-2452.

Ozenberger BB, Li L, Wilson ER, Lazar AJ, Barrott JJ, Jones KB. EWSR1::ATF1 orchestrates the clear cell sarcoma transcriptome in human tumors and a mouse genetic model. Cancers (Basel). 2023 Dec 8;15(24):5750. doi: 10.3390/cancers15245750.

Pozner A, Verma S, Li L, Wang S, Barrott JJ, Nelson M, Yu J, Negri GL, Colborne S, Hughes C, Zhu J, Lambert S, Smith-Fry K, Stewart M, Kannan S, Jensen B, Li J, Vahrenkamp J, Groundland J, Wustrack R, Gertz J, Zhang X, Lazar A, Hirst M, Morin G, Nielsen T, Shen P, Jones K. ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97. Nature Communications. 2024 Feb 7;15(1):1165.

Okojie J, McCollum S, Barrott JJ. The future of antibody drug conjugation by comparing various methods of site-specific conjugation. Discovery Medicine. 2023 Dec 01; 35(179): 921-927.

Afrin F, Mateen S, Oman J, Lai JCK, Barrott JJ, Pashikanti S. Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells. Cancers (Basel). 2023 Sep 20;15(18):4645.

Khajeh Pour S, Mateen S, Pashikanti S, Barrott JJ, Aghazadeh-Habashi A. Formulation, Characterization, and In Vitro/In Vivo Efficacy Studies of a Novel Liposomal Drug Delivery System of Amphiphilic Jaspine B for Treatment of Synovial Sarcoma. Marine Drugs. 2022 Aug 10; 20(8):509.

Fatema K, Larson Z, Barrott JJ. Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs. BIOCELL. 2022 Jun 13;46(10):2177-2193.

McCollum S, Kalivas A, Kirkham M, Kunz K, Okojie J, Pavek A, Barrott JJ. Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma. Pharmaceuticals (Basel). 2022 May 24;15(6):650.